TMX Newsfile

IN THE PRESS

Biosenta Announces Debt Settlement

January 31, 2024

·

7 min read

Drug Development

InFlectis BioScience Completes Enrollment of Its Phase 2 Trial of IFB-088 for the Treatment of Amyotrophic Lateral Sclerosis; Anticipates Initial Results Later This Year

January 31, 2024

·

1 min read

Defence Therapeutics Completes 1st Tranche of Financing

January 31, 2024

·

4 min read

Nextleaf Solutions Ltd. Achieves Strong Fiscal Year 2023 Financial Performance, Debt-Free Status, and Positive Cash Flow from Operations

January 31, 2024

·

8 min read

Business

MYND Life Sciences Announces New Director & Update on the Proposed Merger with Cava Healthcare Inc.

January 30, 2024

·

3 min read

Telo Genomics Engages US Diagnostics Experts to Power Product Adoption in the US

January 30, 2024

·

8 min read

FDA

Izotropic Receives Response From U.S. FDA

January 30, 2024

·

2 min read

Medexus Schedules Third Fiscal Quarter 2024 Conference Call

January 30, 2024

·

3 min read

Nirvana Life Sciences Inc. Announces Receipt of First North American Production of SOSA, a Patented, WHO Approved, Herbal Treatment for Opiate Addiction

January 29, 2024

·

4 min read

Skye Bioscience Announces $50.25 Million Private Placement Equity Financing

January 29, 2024

·

7 min read

15 Toronto St., Suite 601 Toronto ON M5C 2E3 US

Tel: 416-806-1750